Replimune

Replimune REPL Stock

$21.89   -0.409464%
Add to favorites
Market Cap
$2.08B
LOW - HIGH [24H]
$20.78 - $22.16
VOLUME [24H]
$2.02M
P/E Ratio
0
Earnings per share
-$2.79
ISIN
US76029N1063
Price   Prediction

Replimune Price Chart

Sorry, that's all we've gotfor now...

Replimune (REPL) stock price today is 21.89 USD on Tech Market Large (-0.41% on the day). Updated .

Replimune REPL Financial and Trading Overview

Replimune stock price 21.89 USD
Previous Close 21.98 USD
Open 21.78 USD
Bid 15.63 USD x 200
Ask 26.93 USD x 200
Day's Range 20.78 - 22.17 USD
52 Week Range 1.5 - 23.54 USD
Volume 2.02M USD
Avg. Volume 2.58M USD
Market Cap 2.08B USD
Beta (5Y Monthly) 0.927
PE Ratio (TTM) N/A
EPS (TTM) -2.79 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 23.33 USD

REPL Valuation Measures

Enterprise Value 1.89B USD
Trailing P/E N/A
Forward P/E -32.63073
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) N/A
Price/Book (mrq) 10.134258
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -7.214

Trading Information

Replimune Stock Price History

Beta (5Y Monthly) 0.927
52-Week Change 149.60%
S&P500 52-Week Change 13.32%
52 Week High 23.54 USD
52 Week Low 1.5 USD
50-Day Moving Average 14.76 USD
200-Day Moving Average 9.99 USD

REPL Share Statistics

Avg. Volume (3 month) 2.58M USD
Avg. Daily Volume (10-Days) 3.68M USD
Shares Outstanding 94.8M
Float 68.22M
Short Ratio 10
% Held by Insiders 2.69%
% Held by Institutions 116.65%
Shares Short 24.61M
Short % of Float 36.13%
Short % of Shares Outstanding 25.95%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio N/A
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends March 31, 2026
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End March 31, 2027

Profitability

Profit Margin 0%
Operating Margin (ttm) 0%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -43.94%
Return on Equity (ttm) -115.79%

Income Statement

Revenue (ttm) N/A
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) N/A
Gross Profit (ttm) N/A
EBITDA -262636992 USD
Net Income Avi to Common (ttm) -271033984 USD
Diluted EPS (ttm) -2.79
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 307.83M USD
Total Cash Per Share (mrq) 3.25 USD
Total Debt (mrq) 127.19M USD
Total Debt/Equity (mrq) 62.11 USD
Current Ratio (mrq) 7.113
Book Value Per Share (mrq) 2.16

Cash Flow Statement

Operating Cash Flow (ttm) -245546000 USD
Levered Free Cash Flow (ttm) -148296000 USD

Profile of Replimune

Country United States
State MA
City Woburn
Address 500 Unicorn Park Drive
ZIP 01801
Phone 781 222 9600
Website https://www.replimune.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 465

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that expresses an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4. The company was founded in 2015 and is headquartered in Woburn, Massachusetts.

Q&A For Replimune Stock

What is a current REPL stock price?

Replimune REPL stock price today per share is 21.89 USD.

How to purchase Replimune stock?

You can buy REPL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Replimune?

The stock symbol or ticker of Replimune is REPL.

Which industry does the Replimune company belong to?

The Replimune industry is Biotechnology.

How many shares does Replimune have in circulation?

The max supply of Replimune shares is 94.8M.

What is Replimune Price to Earnings Ratio (PE Ratio)?

Replimune PE Ratio is now.

What was Replimune earnings per share over the trailing 12 months (TTM)?

Replimune EPS is -2.79 USD over the trailing 12 months.

Which sector does the Replimune company belong to?

The Replimune sector is Healthcare.

Replimune REPL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite IXIC US 25136.27 USD —
-0.91
7.74B USD — 24872.41 USD — 25423.09 USD — — 7.74B USD —
us US Tech Global Select Market Com NQGS US 12378.66 USD —
-0.9
— — 12248.6 USD — 12520.36 USD — — — —
us US Tech Biotechnology NBI US 7211.27 USD —
-0.5
— — 7149.19 USD — 7238.9 USD — — — —
us US Tech Health Care IXHC US 1368.29 USD —
-0.34
— — 1358.68 USD — 1373.65 USD — — — —
us US Tech US 700 Small Cap Index NQUS700SC US 3020.37 USD —
-0.22
— — 2991.33 USD — 3035.56 USD — — — —
us Stlmt ID US Tech Biotechnology NBX US 4000.62 USD —
-1.26
— — 3927.42 USD — 4148.65 USD — — — —
$2.19T
Total marketcap
$84.64B
Total volume
BTC 59.40%   •   ETH 10.08%
Dominance
Select currency